Review: taking Claritin and Nasacort aq together


Summary

Drug interactions are reported among people who take Claritin and Nasacort aq together. This review analyzes the effectiveness and drug interactions between Claritin and Nasacort aq. It is created by eHealthMe based on reports of 943 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Claritin and Nasacort aq >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Claritin

Claritin has active ingredients of loratadine. It is often used in hypersensitivity. (latest outcomes from Claritin 28,089 users)

Nasacort Aq

Nasacort aq has active ingredients of triamcinolone acetonide. It is often used in hypersensitivity. (latest outcomes from Nasacort aq 939 users)

On Aug, 26, 2016

943 people who take Claritin, Nasacort Aq are studied.


Number of reports submitted per year:

Claritin and Nasacort aq drug interactions.

Drug effectiveness over time:

Claritin:
  • < 1 month: 0.0% - (0 of 3 people)
  • 1 - 6 months: 0.0% - (0 of 2 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 3 people)
  • 2 - 5 years: 0.0% - (0 of 1 people)
  • 5 - 10 years: 100.0% - (3 of 3 people)
  • 10+ years: 100.0% - (2 of 2 people)
  • not specified: 0.0% - (0 of 0 people)
Nasacort Aq:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 50.0% - (1 of 2 people)
  • 6 - 12 months: 50.0% - (1 of 2 people)
  • 1 - 2 years: 100.0% - (2 of 2 people)
  • 2 - 5 years: 50.0% - (1 of 2 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 100.0% - (2 of 2 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Claritin:
  • female: 33.0% - (3 of 9 people)
  • male: 40.0% - (2 of 5 people)
Nasacort Aq:
  • female: 50.0% - (4 of 8 people)
  • male: 100.0% - (4 of 4 people)

Drug effectiveness by age:

Claritin:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 2 people)
  • 10-19: 0.0% - (0 of 2 people)
  • 20-29: 0.0% - (0 of 1 people)
  • 30-39: 0.0% - (0 of 3 people)
  • 40-49: 100.0% - (2 of 2 people)
  • 50-59: 75.0% - (3 of 4 people)
  • 60+: 0.0% - (0 of 0 people)
Nasacort Aq:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 100.0% - (1 of 1 people)
  • 10-19: 0.0% - (0 of 2 people)
  • 20-29: 100.0% - (1 of 1 people)
  • 30-39: 50.0% - (1 of 2 people)
  • 40-49: 50.0% - (1 of 2 people)
  • 50-59: 100.0% - (4 of 4 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • vision blurred
  • cough
  • dyspnoea
  • intraocular pressure increased
  • maculopathy
  • mental disorder
  • photopsia
  • psychomotor hyperactivity
  • retinal vein occlusion
  • status asthmaticus
1 - 6 months:
  • pain
  • anxiety
  • finger swelling
  • abdominal discomfort
  • alopecia
  • anhedonia
  • anorexia
  • chest pain
  • deep vein thrombosis
  • diarrhoea
6 - 12 months:
  • heartburn - chronic
  • incontinence
1 - 2 years:
  • anxiety
  • muscle pain
  • pain - joints
  • tic
  • abscess
  • actinic keratosis
  • alcoholism
  • atelectasis
  • balance disorder
  • bone density decreased
2 - 5 years:
  • abscess
  • actinic keratosis
  • alcoholism
  • atelectasis
  • atypical attention deficit syndrome
  • balance disorder
  • blood pressure increased
  • bone density decreased
  • bronchiectasis
  • bronchitis chronic
5 - 10 years:
  • nasal septum deviation
  • osteoporosis
  • arthralgia
  • biopsy breast abnormal
  • breast cancer
  • breast necrosis
  • dyspnoea
  • fibrocystic breast disease
  • mammogram abnormal
  • musculoskeletal pain
10+ years:
  • increased tendency to bruise
  • leukocytosis
not specified:
  • pain
  • fatigue
  • fall
  • nausea
  • anxiety
  • depression
  • arthralgia
  • dyspnoea
  • asthenia
  • dizziness

Most common drug interactions by gender *:

female:
  • fatigue
  • pain
  • fall
  • anxiety
  • depression
  • nausea
  • arthralgia
  • dyspnoea
  • sinusitis
  • cough
male:
  • pain
  • anxiety
  • nausea
  • dizziness
  • headache
  • chest pain
  • fatigue
  • asthenia
  • depression
  • arthralgia

Most common drug interactions by age *:

0-1:
  • congenital oral malformation
  • foetal exposure during pregnancy
2-9:
  • anxiety
  • muscle pain
  • pain - joints
  • tic
  • dyspepsia
  • gastroenteritis eosinophilic
  • oesophageal candidiasis
  • injection site erythema
  • injection site rash
  • injection site swelling
10-19:
  • nausea
  • anxiety
  • depressed mood
  • dyspnoea
  • headache
  • pain
  • pharyngolaryngeal pain
  • pyrexia
  • abdominal pain upper
  • acquired night blindness
20-29:
  • pain
  • anxiety
  • autoimmune hepatitis
  • cholecystitis chronic
  • deep vein thrombosis
  • emotional distress
  • pancreatitis
  • tardive dyskinesia
  • anaphylactic reaction
  • anhedonia
30-39:
  • fatigue
  • fall
  • rhinorrhoea
  • depression
  • anaemia
  • pain in extremity
  • skin ulcer
  • pruritus
  • gait disturbance
  • osteopenia
40-49:
  • dyspnoea
  • pain
  • cough
  • depression
  • asthma
  • arthralgia
  • nausea
  • sinusitis
  • pain in extremity
  • abdominal pain
50-59:
  • fatigue
  • headache
  • arthralgia
  • nausea
  • pain
  • anxiety
  • vomiting
  • fall
  • diarrhoea
  • dizziness
60+:
  • fall
  • dizziness
  • anxiety
  • diarrhoea
  • osteoarthritis
  • nausea
  • pain
  • fatigue
  • sinusitis
  • chest pain

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Claritin and Nasacort aq?

Can you answer these questions?

More questions for: Claritin, Nasacort aq

You may be interested in these reviews

More reviews for: Claritin, Nasacort aq

On eHealthMe, Claritin (loratadine) is often used to treat hypersensitivity. Nasacort aq (triamcinolone acetonide) is often used to treat hypersensitivity. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.